XML 12 R3.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended9 Months Ended71 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Revenues$ 0$ 0$ 0$ 0$ 0
Costs and Expenses:     
Research and development3,882,8032,295,3627,715,3797,874,49022,709,779
Purchased in-process research and development    28,156,502
General and administrative1,102,8441,220,4274,524,8753,837,72917,423,875
Loss from Operations(4,985,647)(3,515,789)(12,240,254)(11,712,219)(68,290,156)
Interest and investment income20,00023,17164,07084,135252,548
Interest expense  (11,877) (11,877)
Other Income    494,479
Change in fair value of derivative instruments-warrants4,382,796110,9373,346,421110,9373,643,205
Total Other Income4,402,796134,1083,398,614195,0724,378,355
Loss from Continuing Operations(582,851)(3,381,681)(8,841,640)(11,517,147)(63,911,801)
Loss from discontinued operations    (71,821)
Net Loss$ (582,851)$ (3,381,681)$ (8,841,640)$ (11,517,147)$ (63,983,622)
Weighted Average Common Shares Outstanding Basic (in shares)94,617,89290,102,40593,416,80589,002,114 
Weighted Average Common Shares Outstanding Diluted (in shares)94,617,89290,102,40593,416,80589,002,114 
Net Loss per Common Share, Basic and Diluted (in dollars per share)$ (0.01)$ (0.04)$ (0.09)$ (0.13)